Physician Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $222K | Sell |
547
-44
| -7% | -$17.8K | 0.03% | 169 |
|
2025
Q1 | $294K | Sell |
591
-25
| -4% | -$12.4K | 0.05% | 139 |
|
2024
Q4 | $320K | Sell |
616
-29
| -4% | -$15.1K | 0.05% | 133 |
|
2024
Q3 | $387K | Buy |
645
+49
| +8% | +$29.4K | 0.07% | 109 |
|
2024
Q2 | $331K | Sell |
596
-11
| -2% | -$6.11K | 0.06% | 118 |
|
2024
Q1 | $337K | Buy |
607
+20
| +3% | +$11.1K | 0.07% | 117 |
|
2023
Q4 | $325K | Buy |
587
+17
| +3% | +$9.41K | 0.07% | 115 |
|
2023
Q3 | $283K | Buy |
570
+24
| +4% | +$11.9K | 0.07% | 110 |
|
2023
Q2 | $283K | Buy |
546
+45
| +9% | +$23.4K | 0.07% | 116 |
|
2023
Q1 | $291K | Sell |
501
-10
| -2% | -$5.8K | 0.08% | 112 |
|
2022
Q4 | $297K | Sell |
511
-3
| -0.6% | -$1.74K | 0.08% | 112 |
|
2022
Q3 | $281K | Hold |
514
| – | – | 0.09% | 113 |
|
2022
Q2 | $303K | Sell |
514
-25
| -5% | -$14.7K | 0.09% | 111 |
|
2022
Q1 | $303K | Sell |
539
-50
| -8% | -$28.1K | 0.08% | 120 |
|
2021
Q4 | $358K | Sell |
589
-11
| -2% | -$6.69K | 0.09% | 110 |
|
2021
Q3 | $349K | Sell |
600
-2
| -0.3% | -$1.16K | 0.1% | 106 |
|
2021
Q2 | $316K | Hold |
602
| – | – | 0.09% | 113 |
|
2021
Q1 | $280K | Hold |
602
| – | – | 0.09% | 116 |
|
2020
Q4 | $294K | Sell |
602
-2
| -0.3% | -$977 | 0.1% | 108 |
|
2020
Q3 | $290K | Sell |
604
-40
| -6% | -$19.2K | 0.12% | 103 |
|
2020
Q2 | $264K | Sell |
644
-58
| -8% | -$23.8K | 0.11% | 109 |
|
2020
Q1 | $236K | Buy |
+702
| New | +$236K | 0.12% | 95 |
|